275 related articles for article (PubMed ID: 35216224)
1. Atrial Fibrillation and Aortic Ectasia as Complications of Primary Aldosteronism: Focus on Pathophysiological Aspects.
Bollati M; Lopez C; Bioletto F; Ponzetto F; Ghigo E; Maccario M; Parasiliti-Caprino M
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216224
[TBL] [Abstract][Full Text] [Related]
2. Atrial Fibrillation in Primary Aldosteronism.
Pan CT; Tsai CH; Chen ZW; Chang YY; Wu VC; Hung CS; Lin YH;
Horm Metab Res; 2020 Jun; 52(6):357-365. PubMed ID: 32289838
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Aldosterone on Cardiorenal and Metabolic Systems.
Otsuka H; Abe M; Kobayashi H
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982445
[TBL] [Abstract][Full Text] [Related]
4. Atrial fibrillation in primary aldosteronism.
Watson T; Karthikeyan VJ; Lip GY; Beevers DG
J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):190-4. PubMed ID: 19617274
[TBL] [Abstract][Full Text] [Related]
5. Endothelial Dysfunction in Primary Aldosteronism.
Chen ZW; Tsai CH; Pan CT; Chou CH; Liao CW; Hung CS; Wu VC; Lin YH;
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31640178
[TBL] [Abstract][Full Text] [Related]
6. Associated factors and effects of comorbid atrial fibrillation in hypertensive patients due to primary aldosteronism.
Sakaguchi S; Okamoto R; Inoue C; Akao M; Kamemura K; Kurihara I; Takeda Y; Ohno Y; Inagaki N; Rakugi H; Katabami T; Tsuiki M; Tanabe A; Tamura K; Fujita S; Yano Y; Dohi K; ; Naruse M
J Hum Hypertens; 2023 Sep; 37(9):757-766. PubMed ID: 36153382
[TBL] [Abstract][Full Text] [Related]
7. Primary Aldosteronism More Prevalent in Patients With Cardioembolic Stroke and Atrial Fibrillation.
Nguyen V; Tu TM; Mamauag MJB; Lai J; Saffari SE; Aw TC; Ong L; Foo RSY; Chai SC; Fones S; Zhang M; Puar TH
Front Endocrinol (Lausanne); 2022; 13():869980. PubMed ID: 35518929
[TBL] [Abstract][Full Text] [Related]
8. Increased aldosterone-dependent Kv1.5 recycling predisposes to pacing-induced atrial fibrillation in Kcne3-/- mice.
Lisewski U; Koehncke C; Wilck N; Buschmeyer B; Pieske B; Roepke TK
FASEB J; 2016 Jul; 30(7):2476-89. PubMed ID: 26985008
[TBL] [Abstract][Full Text] [Related]
9. Abdominal aortic calcification is more severe in unilateral primary aldosteronism patients and is associated with elevated aldosterone and parathyroid hormone levels.
Tuersun T; Luo Q; Zhang Z; Wang G; Zhang D; Wang M; Wu T; Zhou K; Yue N; Li N
Hypertens Res; 2020 Dec; 43(12):1413-1420. PubMed ID: 32770102
[TBL] [Abstract][Full Text] [Related]
10. Primary aldosteronism and metabolic syndrome.
Fallo F; Pilon C; Urbanet R
Horm Metab Res; 2012 Mar; 44(3):208-14. PubMed ID: 22116746
[TBL] [Abstract][Full Text] [Related]
11. Aldosterone to Renin Ratio as a Screening Instrument for Primary Aldosteronism in a Middle-Aged Population with Atrial Fibrillation.
Mourtzinis G; Ebrahimi A; Gustafsson H; Johannsson G; Manhem K
Horm Metab Res; 2017 Nov; 49(11):831-837. PubMed ID: 28934817
[TBL] [Abstract][Full Text] [Related]
12. Arterial Hypertension, Aldosterone, and Atrial Fibrillation.
Seccia TM; Caroccia B; Maiolino G; Cesari M; Rossi GP
Curr Hypertens Rep; 2019 Nov; 21(12):94. PubMed ID: 31741119
[TBL] [Abstract][Full Text] [Related]
13. The cardiovascular consequences of hyperaldosteronism.
Rossi GP; Seccia TM; Maiolino G; Cesari M
Ann Endocrinol (Paris); 2021 Jun; 82(3-4):174-178. PubMed ID: 32192789
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis.
Monticone S; D'Ascenzo F; Moretti C; Williams TA; Veglio F; Gaita F; Mulatero P
Lancet Diabetes Endocrinol; 2018 Jan; 6(1):41-50. PubMed ID: 29129575
[TBL] [Abstract][Full Text] [Related]
15. Incidence of Atrial Fibrillation and Mineralocorticoid Receptor Activity in Patients With Medically and Surgically Treated Primary Aldosteronism.
Hundemer GL; Curhan GC; Yozamp N; Wang M; Vaidya A
JAMA Cardiol; 2018 Aug; 3(8):768-774. PubMed ID: 30027227
[TBL] [Abstract][Full Text] [Related]
16. Primary Aldosteronism: JACC State-of-the-Art Review.
Rossi GP
J Am Coll Cardiol; 2019 Dec; 74(22):2799-2811. PubMed ID: 31779795
[TBL] [Abstract][Full Text] [Related]
17. Genetics of mineralocorticoid excess: an update for clinicians.
Zennaro MC; Rickard AJ; Boulkroun S
Eur J Endocrinol; 2013 Jul; 169(1):R15-25. PubMed ID: 23610123
[TBL] [Abstract][Full Text] [Related]
18. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism.
Milliez P; Girerd X; Plouin PF; Blacher J; Safar ME; Mourad JJ
J Am Coll Cardiol; 2005 Apr; 45(8):1243-8. PubMed ID: 15837256
[TBL] [Abstract][Full Text] [Related]
19. Primary Aldosteronism and Resistant Hypertension: A Pathophysiological Insight.
Bioletto F; Bollati M; Lopez C; Arata S; Procopio M; Ponzetto F; Ghigo E; Maccario M; Parasiliti-Caprino M
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563192
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of primary aldosteronism and association with cardiovascular complications in patients with resistant and refractory hypertension.
Parasiliti-Caprino M; Lopez C; Prencipe N; Lucatello B; Settanni F; Giraudo G; Rossato D; Mengozzi G; Ghigo E; Benso A; Maccario M
J Hypertens; 2020 Sep; 38(9):1841-1848. PubMed ID: 32384388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
